TL13-110 is primarily utilized in the field of biomedical research, particularly in the study of cancer therapeutics. It functions as a potent inhibitor of specific protein kinases that are involved in cell signaling pathways. By blocking these kinases, TL13-110 helps to halt the proliferation of cancer cells, making it a valuable tool in understanding and developing targeted cancer treatments. Additionally, its application extends to preclinical studies where it is used to evaluate the efficacy and safety of new anticancer drugs, providing insights into potential therapeutic strategies.